Skip to main content
MedPathMedPath Home
Clinical Trials/PACTR201907742980888
PACTR201907742980888
Not yet recruiting
未知

Evaluation of Efficacy and Safety of intramuscular glutathione as a systemic whitening agent: a double blinded randomized controlled clinical trial

Sohag University Hospital0 sites30 target enrollmentApril 22, 2019
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Sohag University Hospital
Enrollment
30
Status
Not yet recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
April 22, 2019
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
Female

Investigators

Sponsor
Sohag University Hospital

Eligibility Criteria

Inclusion Criteria

  • •Healthy female aged between 18 to 50 years old fitzpatric skin type III and V.

Exclusion Criteria

  • •Personal or family history of skin cancer, especially melanoma.
  • •Consumption of any preparations containing glutathione within 1month of enrollment.
  • •Pigmentary disorders or any dermatoses, which may affect the measurement within the study areas.
  • •Known hypersensitivity to glutathione.
  • •Current pregnancy and lactation.
  • •Current use of oral contraceptive pills or current receipt of hormone replacement therapy.
  • •Regular participation in vigorous activities (e.g. sports) that includes exercise; occupational or leisure activities that involve daily sun exposure between 10\.00 hours and 15\.00 hours
  • •A history of autoimmune disease, or immunodeficiency.
  • •Major surgery, active or recent systemic infection within the previous four weeks.
  • •History of liver diseases.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Phase 1
Study for effects of Masport in adultsGlabellar Facial lines.
IRCT201201154536N2Masoondarou Co.12
Completed
Not Applicable
Does selecting the site of injection based on anthropometric indices and body shape reduces the pain of injection?
IRCT20180826040875N1o funding162
Not yet recruiting
Phase 4
Comparison of the effectiveness of intramuscular olanzapine with intramuscular haloperidol for the treatment of agitation in patients with Bipolar DisorderBipolar disorder.Bipolar disorder
IRCT20230131057294N1niversity of social welfare and rehabilitation sciences40
Not yet recruiting
Phase 2
Comparison of the effectiveness of intramuscular injection of Ketorolac with PCA pump Containing Morphine and Apotel in Pain control of Patients after Cesarean SectioPainlessness after surgery.
IRCT20231005059625N1Birjand University of Medical Sciences90
Recruiting
Phase 3
To check the efficiency of two different routes (into the vein and into the muscle) of a medicine that will reduce swelling, pain and improve mouth opening after wisdom tooth removal. The medicine is dexamethasone and it reduces signs of inflammation.
CTRI/2018/10/016164Mehul Saha